Abstract The Infectious Diseases Society of America and the American Association for the
Study of Liver Diseases have collaboratively developed evidence-based guidance …

The burden of HIV/AIDS and other transmissible diseases is higher in prison and jail settings
than in the non-incarcerated communities that surround them. In this comprehensive review …

Background: The prevalence of hepatitis C virus (HCV) in US prisoners is high; however,
HCV testing and treatment are rare. Infected inmates released back into society contribute to …

OBJECTIVES: Prisons are major reservoirs of hepatitis C virus (HCV) in which a therapeutic
approach has been particularly difficult so far. Our aim was to create a permanent program …

When cost-effective interventions are unaffordable: Integrating cost-effectiveness and
budget impact in priority setting for global health programs | PLOS Medicine Skip to main …

Background & Aims Direct-acting antivirals (DAAs) are effective in treatment of hepatitis C
virus (HCV) genotype 1 infection, but their cost and value have been debated. We performed …

Prisoners bear much of the burden of the hepatitis C epidemic in the United States. Yet little
is known about the scope and cost of treating hepatitis C in state prisons—particularly since …

Background New direct-acting antivirals (DAAs) are highly effective for hepatitis C virus
(HCV) treatment. However, their prices have been widely debated. Decision-analytic models …

Abstract The World Health Organization has set tremendous goals to eliminate viral hepatitis
by 2030. However, most countries are currently off the track for achieving these goals …

The studies of economic burden of chronic diseases have generally been falling behind
similar studies related to their epidemiology, morbidity, and mortality. 1 However …